4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-26-000137
Executive Chair sold 26,756 shares at $76.32 ($2,041,999)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SAYER KEVIN R Executive Chair | 2026-07-20 | Sale 10b5-1 | −26,756 | $76.32 | $2,041,999 | 328,970 | D |
| Open-market sales · 26,756 sh · avg $76.32 · $2,041,999 | |||||||
Loading xslF345X06/wk-form4_1784667520.xml…